GENES TECH (08257) announced its results for the six months ended June 30, 2025, reporting revenue of TWD 585 million, representing a 9.4% year-on-year increase. Net profit reached TWD 48.699 million, up 25.8% compared to the same period last year, with basic earnings per share of 4.87 TWD cents.

During the period, the Group maintained its prudent and steady core strategy, focusing on strengthening the stability and continuity of cooperation with existing international clients while actively expanding its customer base to diversify risks.

During the review period, the Group's revenue from US operations increased substantially by 78.54% compared to the previous year, accounting for approximately 38.68% of the Group's total revenue. Meanwhile, revenue from Taiwan operations grew by 48.97% year-on-year, representing about 49.69% of the Group's total revenue.